Januvia vs Onglyza

Januvia
Onglyza
Satisfaction Score
?
2.7
Slightly Satisfied
Satisfaction Score
?
2.6
Slightly Satisfied
Helpfulness
for Diabetes
2.9
Concern level
3.6
Helpfulness
for Diabetes
2.2
Concern level
3.6
11,844
Discussions around the web
Discussions
1,311
Discussions around the web
Discussions
Taken for:
by discussions around the web
Diabetes
Type 2 Diabetes
Taken for:
by discussions around the web
Diabetes
Type 2 Diabetes
Method of use:
Pill
Method of use:
Pill
Prescribing mode:
Rx
Prescribing mode:
Rx
Sitagliptin (International Nonproprietary Name previously identified as MK-0431 and marketed as sitagliptin phosphate under the trade name Januvia) is an oral antihyperglycemic (antidiabetic drug) of the DPP-4 inhibitors class. It was devel...
Read on Wikipedia
Saxagliptin (International Nonproprietary Name), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new DPP-4 inhibitors class of drugs. Early development was solely by Bristol-Myers Squibb in 2007 AstraZe...
Read on Wikipedia
Top Concerns
Jan
Weight Loss
10
Weight Gain
8
Hypoglycemia
7
Nausea
4
Insulin Resistance
3
Hyperglycemia
3
Headaches
3
Pancreatitis
3
Tiredness
2
Diarrhea
2
Top Concerns
Ong
Weight Loss
9
Weight Gain
8
Hypoglycemia
6
Hyperglycemia
4
Nausea
3
Insulin Resistance
3
Pancreatitis
3
Diarrhea
3
Headaches
2
Heart Failure
2
Compare concerns
By:
Januvia
Jan
Onglyza
Ong
Weight Loss
Jan
Ong
10
9
Weight Gain
Jan
Ong
8
8
Hypoglycemia
Jan
Ong
7
6
Nausea
Jan
Ong
4
3
Insulin Resistance
Jan
Ong
3
3
Hyperglycemia
Jan
Ong
3
4
Headaches
Jan
Ong
3
2
Pancreatitis
Jan
Ong
3
3
Tiredness
Jan
Ong
2
0
Diarrhea
Jan
Ong
2
3
Weight Loss
Ong
Jan
9
10
Weight Gain
Ong
Jan
8
8
Hypoglycemia
Ong
Jan
6
7
Hyperglycemia
Ong
Jan
4
3
Nausea
Ong
Jan
3
4
Insulin Resistance
Ong
Jan
3
3
Pancreatitis
Ong
Jan
3
3
Diarrhea
Ong
Jan
3
2
Headaches
Ong
Jan
2
3
Heart Failure
Ong
Jan
2
0
Back
About Januvia
Sitagliptin (International Nonproprietary Name previously identified as MK-0431 and marketed as sitagliptin phosphate under the trade name Januvia) is an oral antihyperglycemic (antidiabetic drug) of the DPP-4 inhibitors class. It was devel...
Read on Wikipedia
Read more about:
Januvia
About Onglyza
Saxagliptin (International Nonproprietary Name), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new DPP-4 inhibitors class of drugs. Early development was solely by Bristol-Myers Squibb in 2007 AstraZe...
Read on Wikipedia
Read more about:
Onglyza
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 254 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Treato does not provide medical advice, diagnoses or treatment. Services are ranked based on reviews gathered from around the web and may refer to different aspects of each service (Price, waiting time, general satisfaction, etc.) Treato does not guarantee any specific rate or promotion. In addition, prices for some services provided by the listed Telehealth companies may vary, please check with the Telehealth site for the exact price for the desired service. Treato is not responsible for promotions validity, application of the promotion code varies among the different Telehealth sites (for example during registration flow). It is your responsibility to apply the promotion code. Treato is not responsible for content on external web sites.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Back to Signup
Please wait...